FLT3 mutation assay laboratory cross validation: results from the CALGB 10603/RATIFY(Alliance) trial in patients with newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
- Citation:
- Blood vol 132 (Suppl) 2800
- Meeting Instance:
- ASH 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3235
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Christian Thiede Thomas Prior Francesco Lo Coco Jürgen Krauter Eva Barragan Josep Nomdedeu Joop H. Jansen Andrew Wei Weiqiang Zhao Xiaohong Li Celine Pallaud Eva Tiecke Richard Larson Clara D. Bloomfield Hartmut Döhner Gerhard Ehninger Richard Stone Konstanze Döhner
- Networks:
- LAPS-IL057, LAPS-MA036, LAPS-OH007
- Study
- CALGB-10603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: